Citations (242)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Einar S. Björnsson & Evangelos Kalaitzakis. (2021) Recent advances in the treatment of primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 15:4, pages 413-425.
Read now
Read now
Michael Dubow, Philip D. Tatman & Raj J. Shah. (2018) Individual probe based confocal laser endomicroscopy criteria in the analysis of indeterminate biliary strictures. Scandinavian Journal of Gastroenterology 53:10-11, pages 1358-1363.
Read now
Read now
James H. Tabibian & Todd H. Baron. (2018) Endoscopic management of primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 12:7, pages 693-703.
Read now
Read now
Seyed Alireza Taghavi, Ahad Eshraghian, Ramin Niknam, Gholam Reza Sivandzadeh & Kamran Bagheri Lankarani. (2018) Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 12:6, pages 575-584.
Read now
Read now
Einar S. Björnsson. (2017) Primary sclerosing cholangitis: best practices for diagnosis. Expert Opinion on Orphan Drugs 5:9, pages 701-706.
Read now
Read now
Sonja Boyd, Harri Mustonen, Andrea Tenca, Kalle Jokelainen, Johanna Arola & Martti A. Färkkilä. (2017) Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma. Scandinavian Journal of Gastroenterology 52:2, pages 242-249.
Read now
Read now
Erik Schrumpf, Kirsten Muri Boberg & Tom H. Karlsen. (2015) Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 50:6, pages 781-796.
Read now
Read now
Alyssa Parian & Mark Lazarev. (2015) Who and how to screen for cancer in at-risk inflammatory bowel disease patients. Expert Review of Gastroenterology & Hepatology 9:6, pages 731-746.
Read now
Read now
Kim Andresen, Kirsten Boberg, Hege Vedeld, Hilde Honne, Merete Hektoen, Chrisopher Wadsworth, Ole Clausen, Tom Karlsen, Aksel Foss, Øystein Mathisen, Erik Schrumpf, Ragnhild Lothe & Guro E. Lind. (2012) Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Epigenetics 7:11, pages 1249-1257.
Read now
Read now
Styrbjörn Friman, Aksel Foss, Helena Isoniemi, Michael Olausson, Krister Höckerstedt, Shinji Yamamoto, Tom Hemming Karlsen, Magnus Rizell & Bo-Göran Ericzon. (2011) Liver transplantation for cholangiocarcinoma: Selection is essential for acceptable results. Scandinavian Journal of Gastroenterology 46:3, pages 370-375.
Read now
Read now
Abhijit S. Bhatia & Anastasios A. Mihas. (2006) Cholestatic liver disease. Postgraduate Medicine 119:1, pages 67-82.
Read now
Read now
Jens J. W. Tischendorf, Peter N. Meier, Christian P. Strassburg, Jürgen Klempnauer, Hartmut Hecker, Michael P. Manns & Martin Krüger. (2006) Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 41:10, pages 1227-1234.
Read now
Read now
B. Brandsæter, S. Friman, U. Broomé, H. Isoniemi, M. Olausson, L. Bäckman, B. Hansen, E. Schrumpf, A. Oksanen, B.‐G. Ericzon, K. Höckerstedt, H. Mäkisalo, P. Kirkegaard & K. Bjøro. (2003) Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scandinavian Journal of Gastroenterology 38:11, pages 1176-1183.
Read now
Read now
Articles from other publishers (229)
Christoph Schramm, Ayaz Sapuk, Dieter Hoyer, Sonia Radünz & Hartmut Schmidt. (2024) Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study. TumorDiagnostik & Therapie 45:04, pages 256-261.
Crossref
Crossref
Martin Cornillet, Christina Villard, Fredrik Rorsman, Antonio Molinaro, Emma Nilsson, Stergios Kechagias, Erik von Seth & Annika Bergquist. (2024) The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM). eClinicalMedicine 70, pages 102526.
Crossref
Crossref
Alejandro Mínguez, Isabel Conde, Cristina Montón, Lara Gonzalez, Sonia Pascual, María Dolores Antón, Antonio Palau, Ana Forés, Concha Gisbert, Asunción Ojeda, Eva Girona, Tommaso Di Maira & Marina Berenguer. (2024) Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region. Digestive Diseases and Sciences.
Crossref
Crossref
Bettina Langhans, Sandra Kalthoff, Taotao Zhou, Tobias J. Weismüller, Henrike Lenzen, Hans Dieter Nischalke, Christian P. Strassburg, Philipp Lutz & Leona Dold. (2024)
Role of
PAR1
−506 deletion/insertion polymorphism in primary sclerosing cholangitis
. Hepatology Research.
Crossref
Crossref
Christina Villard, Carl Jorns & Annika Bergquist. (2024) Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review. eGastroenterology 2:1, pages e100045.
Crossref
Crossref
Maria Consiglia Bragazzi, Rosanna Venere, Emanuela Ribichini, Francesco Covotta, Vincenzo Cardinale & Domenico Alvaro. (2024) Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment. Digestive and Liver Disease 56:3, pages 383-393.
Crossref
Crossref
Daniel Saca & Steven L. Flamm. (2024) Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis. Clinics in Liver Disease 28:1, pages 183-192.
Crossref
Crossref
Christoph Schramm, Ayaz Sapuk, Dieter Hoyer, Sonia Radünz & Hartmut Schmidt. (2024) Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study. Zeitschrift für Gastroenterologie 62:01, pages 37-42.
Crossref
Crossref
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano & Aileen Wee. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
842
946
.
Enni Vanhanen, Ali Ovissi, Kaija-Leena Kolho & Andrea Tenca. (2023) Magnetic resonance cholangiography in the diagnosis of dominant strictures in pediatric-onset primary sclerosing cholangitis. Digestive and Liver Disease 55:11, pages 1496-1501.
Crossref
Crossref
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra & Martina Gambato. (2023) Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. Cancers 15:20, pages 4947.
Crossref
Crossref
Rikita I. Hatia, Madhulika Eluri, Ernest T. Hawk, Akram Shalaby, Elif Karatas, Ahmed Shalaby, Ahmed Abdelhakeem, Reham Abdel-Wahab, Ping Chang, Asif Rashid, Prasun K. Jalal, Christopher I. Amos, Younghun Han, Tannaz Armaghany, Rachna T. Shroff, Donghui Li, Milind Javle & Manal M. Hassan. (2023) Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiology, Biomarkers & Prevention 32:10, pages 1338-1347.
Crossref
Crossref
Domenico Alvaro, Gregory J. Gores, Joël Walicki, Cesare Hassan, Gonzalo Sapisochin, Mina Komuta, Alejandro Forner, Juan W. Valle, Andrea Laghi, Sumera I. Ilyas, Joong-Won Park, Robin K. Kelley, Maria Reig & Bruno Sangro. (2023) EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. Journal of Hepatology 79:1, pages 181-208.
Crossref
Crossref
Ainhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, Paula Olaizola, Ekaterina Zhuravleva, Marit M. Grimsrud, Christoph Schramm, Ander Arbelaiz, Colm J. O'Rourke, Adelaida La Casta, Malgorzata Milkiewicz, Tania Pastor, Mette Vesterhus, Raul Jimenez-Agüero, Michael T. Dill, Angela Lamarca, Juan W. Valle, Rocio I.R. Macias, Laura Izquierdo-Sanchez, Ylenia Pérez Castaño, Francisco Javier Caballero-Camino, Ioana Riaño, Marcin Krawczyk, Cesar Ibarra, Javier Bustamante, Luiz M. Nova-Camacho, Juan M. Falcon-Perez, Felix Elortza, Maria J. Perugorria, Jesper B. Andersen, Luis Bujanda, Tom H. Karlsen, Trine Folseraas, Pedro M. Rodrigues & Jesus M. Banales. (2023) Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma. Journal of Hepatology 79:1, pages 93-108.
Crossref
Crossref
Takahiro Miyazu, Natsuki Ishida, Yusuke Asai, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Satoshi Baba & Ken Sugimoto. (2023) Intrahepatic cholangiocarcinoma in patients with primary sclerosing cholangitis and ulcerative colitis: Two case reports. World Journal of Gastrointestinal Surgery 15:6, pages 1224-1231.
Crossref
Crossref
Leona Dold, Leonie Frank, Philipp Lutz, Dominik J. Kaczmarek, Benjamin Krämer, Jacob Nattermann, Tobias J. Weismüller, Vittorio Branchi, Marieta Toma, Maria Gonzalez-Carmona, Christian P. Strassburg, Ulrich Spengler & Bettina Langhans. (2023) IL-6-DEPENDENT STAT3 ACTIVATION AND INDUCTION OF PROINFLAMMATORY CYTOKINES IN PRIMARY SCLEROSING CHOLANGITIS. Clinical and Translational Gastroenterology Publish Ahead of Print.
Crossref
Crossref
Chang Hu, Ravishankar K. Iyer, Brian D. Juran, Bryan M. McCauley, Elizabeth J. Atkinson, John E. Eaton, Ahmad H. Ali & Konstantinos N. Lazaridis. (2023) Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data. BMC Gastroenterology 23:1.
Crossref
Crossref
Eline J.C. A. Kamp, Winand N.M. Dinjens, Marie-Louise F. van Velthuysen, Pieter Jan F. de Jonge, Marco J. Bruno, Maikel P. Peppelenbosch & Annemarie C. de Vries. (2023) Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis. Gastrointestinal Endoscopy 97:3, pages 456-465.e6.
Crossref
Crossref
Rakesh Sahu, Praveen Sharma & Ajay Kumar. (2022) An Insight into Cholangiocarcinoma and Recent Advances in its Treatment. Journal of Gastrointestinal Cancer 54:1, pages 213-226.
Crossref
Crossref
Vincenza Granata, Roberta Fusco, Federica De Muzio, Carmen Cutolo, Francesca Grassi, Maria Chiara Brunese, Igino Simonetti, Orlando Catalano, Michela Gabelloni, Silvia Pradella, Ginevra Danti, Federica Flammia, Alessandra Borgheresi, Andrea Agostini, Federico Bruno, Pierpaolo Palumbo, Alessandro Ottaiano, Francesco Izzo, Andrea Giovagnoni, Antonio Barile, Nicoletta Gandolfo & Vittorio Miele. (2023) Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence. Biology 12:2, pages 213.
Crossref
Crossref
Chunyue Yin. (2023) Endothelin Signaling Mediates Biliary-Endothelial Crosstalk in Primary Sclerosing Cholangitis. Cellular and Molecular Gastroenterology and Hepatology 16:4, pages 643-645.
Crossref
Crossref
Linda Skibsted Kornerup, Lisbet Grønbæk, Mikkel Breinholt Kjær & Henning Grønbæk. 2023. Comprehensive Guide to Hepatitis Advances. Comprehensive Guide to Hepatitis Advances
429
441
.
Steffi Lopens, Ewa Wunsch, Malgorzata Milkiewicz, Nadja Röber, Grit Zarske, Abdullah Nasser, Karsten Conrad, Martin Laass, Stefan Rödiger, Marcin Krawczyk, Dirk Roggenbuck & Piotr Milkiewicz. (2022) PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis. Diagnostics 12:11, pages 2682.
Crossref
Crossref
Mohamed Attauabi, Mads Damsgaard Wewer, Flemming Bendtsen, Jakob Benedict Seidelin & Johan Burisch. (2022) Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. Inflammatory Bowel Diseases 28:11, pages 1756-1765.
Crossref
Crossref
Eline JCA Kamp, Winand NM Dinjens, Michail Doukas, Ronald van Marion, Joanne Verheij, Cyriel Y Ponsioen, Marco J Bruno, Bas Groot Koerkamp, Palak J Trivedi, Maikel P Peppelenbosch & Annemarie C de Vries. (2022) Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis. The Journal of Pathology 258:3, pages 227-235.
Crossref
Crossref
Natassia Tan, N. Ngu, T. Worland, T. Lee, T. Abrahams, K. Pandya, E. Freeman, N. Hannah, K. Gazelakis, R. G. Madden, K. D. Lynch, Z. Valaydon, S. Sood, A. Dev, S. Bell, A. Thompson, J. Ding, A. J. Nicoll, K. Liu, P. Gow, J. Lubel, W. Kemp, S. K. Roberts & A. Majeed. (2022) Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study. Hepatology International 16:5, pages 1094-1104.
Crossref
Crossref
Vartika Agrawal, Yeshwant Lamture & Sangeeta Totade. (2022) A Typical Case of an Atypical Disease: Klatskin Tumor. Cureus.
Crossref
Crossref
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm & Michael Trauner. (2022) EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 77:3, pages 761-806.
Crossref
Crossref
Yujie Zhang, Xinbao Gao, Zhiyi He, Hui Jia, Min Chen, Xuan Wang, Liu Hong, Yuanyuan Cui & Jian Wan. (2022) Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta‐analysis. Liver International 42:8, pages 1814-1822.
Crossref
Crossref
Yu Huang, Shuai Zhang, Jie-Feng Weng, Di Huang & Wei-Li Gu. (2022) Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis. Open Medicine 17:1, pages 915-929.
Crossref
Crossref
Nadir Abbas, Mohammad Nabil Quraishi & Palak Trivedi. (2022) Emerging drugs for the treatment of primary sclerosing cholangitis. Current Opinion in Pharmacology 62, pages 23-35.
Crossref
Crossref
Felix Krenzien, Nora Nevermann, Alina Krombholz, Christian Benzing, Philipp Haber, Uli Fehrenbach, Georg Lurje, Uwe Pelzer, Johann Pratschke, Moritz Schmelzle & Wenzel Schöning. (2022) Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach. Cancers 14:2, pages 362.
Crossref
Crossref
James Hawken, Gautham Appanna & A J Portal. (2022) Is it time for recommendations to reflect reality in PSC surveillance?. Frontline Gastroenterology 13:1, pages 88-89.
Crossref
Crossref
Tina Boortalary & David Loren. 2022. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
237
264
.
Anastasia Mala, Kalliopi Foteinogiannopoulou & Ioannis E Koutroubakis. (2021) Solid extraintestinal malignancies in patients with inflammatory bowel disease. World Journal of Gastrointestinal Oncology 13:12, pages 1956-1980.
Crossref
Crossref
Francesca Saffioti & Vasileios K Mavroeidis. (2021) Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World Journal of Gastrointestinal Oncology 13:10, pages 1336-1366.
Crossref
Crossref
Ali Reza Safarpour, Hassan Askari, Farshid Ejtehadi, Asaad Azarnezhad, Ehsan Raeis-Abdollahi, Amir Tajbakhsh, Mohammad Foad Abazari, Firoozeh Tarkesh, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Kamran Bagheri Lankarani & Fardad Ejtehadi. (2021) Cholangiocarcinoma and liver transplantation: What we know so far?. World Journal of Gastrointestinal Pathophysiology 12:5, pages 84-105.
Crossref
Crossref
Terrance Rodrigues & Justin R. Boike. (2021) Biliary Strictures: Etiologies and Medical Management. Seminars in Interventional Radiology 38:03, pages 255-262.
Crossref
Crossref
Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matías A. Ávila, Yulia A. Nevzorova & Francisco Javier Cubero. (2021) Fibrotic Events in the Progression of Cholestatic Liver Disease. Cells 10:5, pages 1107.
Crossref
Crossref
Purnima Bhat & Lars Aabakken. (2021) Role of Endoscopy in Primary Sclerosing Cholangitis. Clinical Endoscopy 54:2, pages 193-201.
Crossref
Crossref
Consolato M. Sergi. 2021. Liver Cancer. Liver Cancer
1
38
.
Ewa Wunsch, Gary L. Norman, Malgorzata Milkiewicz, Marcin Krawczyk, Chelsea Bentow, Zakera Shums, Michael Mahler, Steffi Lopens, Dirk Reinhold, Andre Franke, Christoph Schramm, Dirk Roggenbuck & Piotr Milkiewicz. (2020) Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 53:2, pages 302-313.
Crossref
Crossref
Jae Hoon Lim, Kee-Taek Jang & Jung Hoon KimJae Hoon Lim, Kee-Taek Jang & Jung Hoon Kim. 2021. Neoplasms of the Biliary Tract. Neoplasms of the Biliary Tract
49
58
.
Tina Boortalary & David Loren. 2021. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
1
28
.
Kazuma Daiku, Kazuto Fukuda, Osakuni Morimoto, Daisuke Takiuchi, Hiromi Shimakoshi, Tadashi Kegasawa, Yoshitaka Yamaguchi, Sachiyo Kogita, Yoshiyuki Sawai, Masanori Nakahara, Takumi Igura, Kunitaka Shibata & Yasuharu Imai. (2020) Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitis. Clinical Journal of Gastroenterology 13:6, pages 1273-1279.
Crossref
Crossref
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Emilio Di Giulio, Giuseppe Tonini, Francesco Pantano, Rosanna Venere, Maria Consiglia Bragazzi, Francesca Biancanello, Jessica Faccioli, Aurora Giannetti, Marcello Cintolo, Michela Di Giunta, Martina Gambato, Alberto Lasagni, Francesco Izzo, Antonio Avallone, Jesus Banales, Massimo Rossi, Carlo Catalano, Andrea Laghi, Giulia D'amati, Maria Grazia Mancino & Lorenzo Ridola. (2020) Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging. Digestive and Liver Disease 52:11, pages 1282-1293.
Crossref
Crossref
Hege Marie Vedeld, Trine Folseraas & Guro Elisabeth Lind. (2020) Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers. JHEP Reports 2:5, pages 100143.
Crossref
Crossref
Tomáš Fejfar, Tomáš Vaňásek & Petr Hůlek. (2020) Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis. Vnitřní lékařství 66:5, pages 287-300.
Crossref
Crossref
Mette Vesterhus, Benedetta Terziroli Beretta‐Piccoli, Kirsten Muri Boberg & Giorgina Mieli‐Vergani. 2020. Autoimmune Liver Disease. Autoimmune Liver Disease
143
161
.
Junmin Song, Yang Li, Christopher L. Bowlus, GuoXiang Yang, Patrick S. C. Leung & M. Eric Gershwin. (2019) Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clinical Reviews in Allergy & Immunology 58:1, pages 134-149.
Crossref
Crossref
E.J.C.A. Kamp, A.C. de Vries & Marco J Bruno. 2020. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
392
405
.
Christopher L. Bowlus. 2020. Liver Immunology. Liver Immunology
395
418
.
Scott M. Thompson, Lorena Marcano-Bonilla, Taofic Mounajjed, Benjamin R. Kipp, Julie K. Heimbach, Christopher L. Hallemeier, Mitesh J. Borad & Lewis R. Roberts. 2020. Evaluation and Management of Liver Masses. Evaluation and Management of Liver Masses
31
61
.
Joseph C. Ahn & Ju Dong Yang. (2019) Screening Indications and Treatments for Cholangiocarcinoma. Current Hepatology Reports 18:4, pages 408-416.
Crossref
Crossref
Christopher L. Bowlus, Joseph K. Lim & Keith D. Lindor. (2019) AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review. Clinical Gastroenterology and Hepatology 17:12, pages 2416-2422.
Crossref
Crossref
. (2019) UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 7:S8, pages 189-1030.
Crossref
Crossref
Alan W. Hemming. (2019) Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 28:4, pages 519-538.
Crossref
Crossref
Michael Huw Chapman, Douglas Thorburn, Gideon M Hirschfield, George G J Webster, Simon M Rushbrook, Graeme Alexander, Jane Collier, Jessica K Dyson, David EJ Jones, Imran Patanwala, Collette Thain, Martine Walmsley & Stephen P Pereira. (2019) British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut 68:8, pages 1356-1378.
Crossref
Crossref
Bijan Eghtesad & John J. Fung. 2019. Pouchitis and Ileal Pouch Disorders. Pouchitis and Ileal Pouch Disorders
487
493
.
Lars Bossen, Alessio Gerussi, Vasiliki Lygoura, George F. Mells, Marco Carbone & Pietro Invernizzi. (2018) Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews 17:9, pages 854-865.
Crossref
Crossref
S. Keller, S.K. Venkatesh, M. Avanesov, J.M. Weinrich, R. Zenouzi, C. Schramm, G. Adam & J. Yamamura. (2018) Gadolinium-based relative contrast enhancement in primary sclerosing cholangitis: additional benefit for clinicians?. Clinical Radiology 73:7, pages 677.e1-677.e6.
Crossref
Crossref
Mai Sedki & Cynthia Levy. (2018) Update in the Care and Management of Patients with Primary Sclerosing Cholangitis. Current Gastroenterology Reports 20:7.
Crossref
Crossref
Tom Hemming Karlsen & Kirsten Muri Boberg. 2018. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
341
354
.
Daniel Zamora-Valdes & Julie K. Heimbach. (2018) Liver Transplant for Cholangiocarcinoma. Gastroenterology Clinics of North America 47:2, pages 267-280.
Crossref
Crossref
Jessica K Dyson, Ulrich Beuers, David E J Jones, Ansgar W Lohse & Mark Hudson. (2018) Primary sclerosing cholangitis. The Lancet 391:10139, pages 2547-2559.
Crossref
Crossref
T. Liwinski & C. Schramm. (2018) Primär sklerosierende CholangitisPrimary sclerosing cholangitis. Der Internist 59:6, pages 551-559.
Crossref
Crossref
Ahmad Hassan Ali, James H. Tabibian, Navine Nasser‐Ghodsi, Ryan J. Lennon, Thomas DeLeon, Mitesh J. Borad, Moira Hilscher, Marina G. Silveira, Elizabeth J. Carey & Keith D. Lindor. (2018) Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology 67:6, pages 2338-2351.
Crossref
Crossref
James H. Tabibian & Christopher L. Bowlus. (2018) WITHDRAWN: Primary sclerosing cholangitis: A review and update. Liver Research.
Crossref
Crossref
Huijiang Zhou, Jiangfeng Xu, Shuai Wang & Jinfeng Peng. (2018) Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines. Molecular Medicine Reports.
Crossref
Crossref
Brian K. Chung, Tom Hemming Karlsen & Trine Folseraas. (2018) Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:4, pages 1390-1400.
Crossref
Crossref
Amanda Ricciuto, Binita M. Kamath & Anne M. Griffiths. (2018) The IBD and PSC Phenotypes of PSC-IBD. Current Gastroenterology Reports 20:4.
Crossref
Crossref
Jennifer R. Newsome, Rajkumar Venkatramani, Andras Heczey, Heather E. Danysh, Douglas S. Fishman & Tamir Miloh. (2018) Cholangiocarcinoma Among Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition 66:1.
Crossref
Crossref
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano & Aileen Wee. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver
780
879
.
Nataliya Razumilava, Konstantinos N. Lazaridis & Gregory J. Gores. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
693
707.e4
.
James H. Tabibian & Christopher L. Bowlus. (2017) Primary sclerosing cholangitis: A review and update. Liver Research 1:4, pages 221-230.
Crossref
Crossref
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn & Mette Vesterhus. (2017) Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 67:6, pages 1298-1323.
Crossref
Crossref
Joanne Skinner, Louis Peters, Tomas Partington & Ashley Barnabas. (2017) Cancer screening and diagnosis in primary sclerosing cholangitis. Gastrointestinal Nursing 15:Sup5, pages S23-S28.
Crossref
Crossref
Evangelos Kalaitzakis & Einar S. Björnsson. (2017) Predictors of the Clinical Course of Primary Sclerosing Cholangitis. Gastroenterology 152:8, pages 1829-1830.
Crossref
Crossref
Tobias J. Weismüller, Palak J. Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen, Cyriel Y. Ponsioen, Kristian Holm, Daniel Gotthardt, Martti A. Färkkilä, Hanns-Ulrich Marschall, Douglas Thorburn, Rinse K. Weersma, Johan Fevery, Tobias Mueller, Olivier Chazouillères, Kornelius Schulze, Konstantinos N. Lazaridis, Sven Almer, Stephen P. Pereira, Cynthia Levy, Andrew Mason, Sigrid Naess, Christopher L. Bowlus, Annarosa Floreani, Emina Halilbasic, Kidist K. Yimam, Piotr Milkiewicz, Ulrich Beuers, Dep K. Huynh, Albert Pares, Christine N. Manser, George N. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, Maria Benito de Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen & Kirsten M. Boberg. (2017) Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology 152:8, pages 1975-1984.e8.
Crossref
Crossref
Lars Aabakken, Tom H. Karlsen, Jörg Albert, Marianna Arvanitakis, Olivier Chazouilleres, Jean-Marc Dumonceau, Martti Färkkilä, Peter Fickert, Gideon M. Hirschfield, Andrea Laghi, Marco Marzioni, Michael Fernandez, Stephen P. Pereira, Jürgen Pohl, Jan-Werner Poley, Cyriel Y. Ponsioen, Christoph Schramm, Fredrik Swahn, Andrea Tringali & Cesare Hassan. (2017) Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Journal of Hepatology 66:6, pages 1265-1281.
Crossref
Crossref
Marko J. Vannas, Sonja Boyd, Martti A. Färkkilä, Johanna Arola & Helena Isoniemi. (2016) Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis. Liver International 37:5, pages 735-742.
Crossref
Crossref
Hanno Ehlken, Roman Zenouzi & Christoph Schramm. (2017) Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. Current Opinion in Gastroenterology 33:2, pages 78-84.
Crossref
Crossref
Pierre Bedossa & Valérie Paradis. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
1272
1298.e7
.
James H. Tabibian, Konstantinos N. Lazaridis & Nicholas F. LaRusso. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
663
674.e5
.
Melinda J. Yeh, So Yeon Kim, Kartik S. Jhaveri, Spencer C. Behr, Nieun Seo & Benjamin M. Yeh. (2016) Imaging of autoimmune biliary disease. Abdominal Radiology 42:1, pages 3-18.
Crossref
Crossref
Palak J. Trivedi & Tom H. Karlsen. 2017. Biliary Disease. Biliary Disease
183
218
.
Hazem T. Hammad & Raj J. Shah. 2017. Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis
181
193
.
José Franco. 2017. Liver Disorders. Liver Disorders
289
305
.
Roman Zenouzi, Tobias J. Weismüller, Kristin K. Jørgensen, Michael Bubenheim, Henrike Lenzen, Peter Hübener, Kornelius Schulze, Christina Weiler-Normann, Marcial Sebode, Hanno Ehlken, Nadine Pannicke, Johannes Hartl, Moritz Peiseler, Sina Hübener, Tom H. Karlsen, Kirsten M. Boberg, Michael P. Manns, Ansgar W. Lohse & Christoph Schramm. (2016) No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 14:12, pages 1806-1812.
Crossref
Crossref
Han Zhang, Tian Yang, Mengchao Wu & Feng Shen. (2016) Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management. Cancer Letters 379:2, pages 198-205.
Crossref
Crossref
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin & Domenico Alvaro. (2016) Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 13:5, pages 261-280.
Crossref
Crossref
Aliya F Gulamhusein, John E Eaton, James H Tabibian, Elizabeth J Atkinson, Brian D Juran & Konstantinos N Lazaridis. (2016) Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD. American Journal of Gastroenterology 111:5, pages 705-711.
Crossref
Crossref
Juliana Rodrigues & David L. Diehl. (2016) Cholangiocarcinoma: Clinical manifestations and diagnosis. Techniques in Gastrointestinal Endoscopy 18:2, pages 75-82.
Crossref
Crossref
Ufuk Barış Kuzu, Bülent Ödemiş, Nuretdin Suna, Hakan Yıldız, Erkan Parlak, Selçuk Dişibeyaz, Serkan Torun, Muhammet Yener Akpınar, Orhan Coşkun, Nesrin Turhan, Mahmut Yüksel & Ertuğrul Kayaçetin. (2015) The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience. Journal of Gastrointestinal Cancer 47:1, pages 8-14.
Crossref
Crossref
Trine Folseraas & Kirsten Muri Boberg. (2016) Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease 20:1, pages 79-98.
Crossref
Crossref
Palak J. Trivedi, Christophe Corpechot, Albert Pares & Gideon M. Hirschfield. (2015) Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists. Hepatology 63:2, pages 644-659.
Crossref
Crossref
Martha M. Kirstein & Arndt Vogel. (2016) Epidemiology and Risk Factors of Cholangiocarcinoma. Visceral Medicine 32:6, pages 395-400.
Crossref
Crossref
Valery Hrad, Yoftahe Abebe, Syed Haris Ali, Jared Velgersdyk, Mohammed Al Hallak & Mohamad Imam. (2016) Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterology Research and Practice 2016, pages 1-9.
Crossref
Crossref
Jason Ho & Steven A. Curley. 2016. Gastrointestinal Malignancies. Gastrointestinal Malignancies
121
163
.
José Franco. 2016. Pancreas and Biliary Disease. Pancreas and Biliary Disease
321
346
.
Paulo Lisboa Bittencourt, Eduardo Luiz Rachid Cançado, Cláudia Alves Couto, Cynthia Levy, Gilda Porta, Antônio Eduardo Benedito Silva, Debora Raquel Benedita Terrabuio, Roberto José de Carvalho Filho, Dalton Marques Chaves, Irene Kazue Miura, Liana Codes, Luciana Costa Faria, Andreia Silva Evangelista, Alberto Queiroz Farias, Luciana Lofêgo Gonçalves, Michele Harriz, Edmundo Pessoa A Lopes Neto, Gustavo Oliveira Luz, Patrícia Oliveira, Elze Maria Gomes de Oliveira, Janaina Luz Narciso Schiavon, Tiago Seva-Pereira & Edison Roberto Parise. (2015) Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver. Arquivos de Gastroenterologia 52:suppl 1, pages 15-46.
Crossref
Crossref
Sumera I. Ilyas, John E. Eaton & Gregory J. Gores. (2015) Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. Clinical Gastroenterology and Hepatology 13:12, pages 2152-2165.
Crossref
Crossref
Kartik S. Jhaveri & Hooman Hosseini‐Nik. (2014) MRI of cholangiocarcinoma. Journal of Magnetic Resonance Imaging 42:5, pages 1165-1179.
Crossref
Crossref
Katherine E. Poruk, Timothy M. Pawlik & Matthew J. Weiss. (2015) Perioperative Management of Hilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery 19:10, pages 1889-1899.
Crossref
Crossref
A. Dohan, S.A. Faraoun, M. Barral, Y. Guerrache, M. Boudiaf, X. Dray, C. Hoeffel, M. Allez, O. Farges, L. Beaugerie, T. Aparicio, P. Marteau, E.K. Fishman, O. Lucidarme, C. Eveno, M. Pocard, R. Dautry & P. Soyer. (2015) Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features. Diagnostic and Interventional Imaging 96:9, pages 871-883.
Crossref
Crossref
James H. Tabibian, Ania Moradkhani & Mark D. Topazian. (2015) Colorectal cancer surveillance in primary sclerosing cholangitis and inflammatory bowel disease. Annals of Hepatology 14:4, pages 564-566.
Crossref
Crossref
Mette Vesterhus, Johannes Roksund Hov, Anders Holm, Erik Schrumpf, Ståle Nygård, Kristin Godang, Ina Marie Andersen, Sigrid Næss, Douglas Thorburn, Francesca Saffioti, Morten Vatn, Odd Helge Gilja, Fridtjof Lund‐Johansen, Trygve Syversveen, Knut Brabrand, Albert Parés, Cyriel Y. Ponsioen, Massimo Pinzani, Martti Färkkilä, Bjørn Moum, Thor Ueland, Helge Røsjø, William Rosenberg, Kirsten Muri Boberg & Tom H. Karlsen. (2015) Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis. Hepatology 62:1, pages 188-197.
Crossref
Crossref
Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, Hilde Honne, Peter Jebsen, Merete Hektoen, Christopher A. Wadsworth, Ole Petter Clausen, Knut E.A. Lundin, Vemund Paulsen, Aksel Foss, Øystein Mathisen, Lars Aabakken, Erik Schrumpf, Ragnhild A. Lothe & Guro E. Lind. (2015) Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology 61:5, pages 1651-1659.
Crossref
Crossref
Annika Bergquist & Erik von Seth. (2015) Epidemiology of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 29:2, pages 221-232.
Crossref
Crossref
Ruben R. Plentz & Nisar P. Malek. (2015) Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 29:2, pages 245-252.
Crossref
Crossref
Linda D. Ferrell, Ryan M. Gill & Kim R. Geisinger. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
2110
2145
.
Sang Hoon LeeSeung Woo Park. (2015) Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer. The Korean Journal of Gastroenterology 66:6, pages 325.
Crossref
Crossref
Zhi-Yuan Mao. (2015) Prognostic value of neutrophil distribution in cholangiocarcinoma. World Journal of Gastroenterology 21:16, pages 4961.
Crossref
Crossref
Wenzel Schöning, Maximilian Schmeding, Florian Ulmer, Anne Andert & Ulf Neumann. (2015) Liver Transplantation for Patients with Cholestatic Liver Diseases. Visceral Medicine 31:3, pages 194-198.
Crossref
Crossref
T.J. Weismüller, T.O. Lankisch & T. Voigtländer. (2014) Kolonkarzinom und Gallengangskarzinom bei primär sklerosierender CholangitisColon cancer and cholangiocarcinoma in primary sclerosing cholangitis. Der Gastroenterologe 10:1, pages 26-31.
Crossref
Crossref
Kamran Qureshi, Randhir Jesudoss & Abdullah M. S. Al-Osaimi. (2014) The Treatment of Cholangiocarcinoma: a Hepatologist?s Perspective. Current Gastroenterology Reports 16:10.
Crossref
Crossref
Steven P. O’Hara, Sergio A. Gradilone, Tetyana V. Masyuk, James H. Tabibian & Nicholas F. LaRusso. (2014) MicroRNAs in Cholangiopathies. Current Pathobiology Reports 2:3, pages 133-142.
Crossref
Crossref
B. Eksteen. (2014) Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis. British Medical Bulletin 110:1, pages 89-98.
Crossref
Crossref
Nataliya Razumilava & Gregory J Gores. (2014) Cholangiocarcinoma. The Lancet 383:9935, pages 2168-2179.
Crossref
Crossref
James H. Tabibian, Felicity Enders, Mohamad H. Imam, Gururaj Kolar, Keith D. Lindor & Jayant A. Talwalkar. (2014) Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis. Annals of Hepatology 13:3, pages 384-389.
Crossref
Crossref
T. H. Karlsen, M. Vesterhus & K. M. Boberg. (2013) Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 39:3, pages 282-301.
Crossref
Crossref
?? ?. (2014) Typing, Risk Factors and Related Treatments of Cholangiocarcinoma. Advances in Clinical Medicine 04:04, pages 74-80.
Crossref
Crossref
Kate D. Williamson & Roger W. Chapman. (2014) Primary Sclerosing Cholangitis. Digestive Diseases 32:4, pages 438-445.
Crossref
Crossref
Panagiotis Trilianos, Florin Selaru, Zhiping Li & Ahmet Gurakar. (2014) Trends in Pre-Liver Transplant Screening for Cholangiocarcinoma among Patients with Primary Sclerosing Cholangitis. Digestion 89:2, pages 165-173.
Crossref
Crossref
Marco Carbone & James M. Neuberger. (2014) Autoimmune liver disease, autoimmunity and liver transplantation. Journal of Hepatology 60:1, pages 210-223.
Crossref
Crossref
Ijeoma A. Azodo, Rowan W. Parks & O. James Garden. 2014. Biliary Tract and Gallbladder Cancer. Biliary Tract and Gallbladder Cancer
1
31
.
Meredith Borman & Bertus Eksteen. 2014. Cholestatic Liver Disease. Cholestatic Liver Disease
51
85
.
Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Erik A. Rauws, B.W. Marcel Spanier, Alexander C. Poen, Karin M. van Nieuwkerk, Joost P. Drenth, Ben J. Witteman, Hans A. Tuynman, Anton H. Naber, Paul J. Kingma, Henk R. van Buuren, Bart van Hoek, Frank P. Vleggaar, Nan van Geloven, Ulrich Beuers & Cyriel Y. Ponsioen. (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58:6, pages 2045-2055.
Crossref
Crossref
Gideon M Hirschfield, Tom H Karlsen, Keith D Lindor & David H Adams. (2013) Primary sclerosing cholangitis. The Lancet 382:9904, pages 1587-1599.
Crossref
Crossref
Mohamad H. Imam, Jayant A. Talwalkar & Keith D. Lindor. (2013) Clinical management of autoimmune biliary diseases. Journal of Autoimmunity 46, pages 88-96.
Crossref
Crossref
Palak J. Trivedi & David H. Adams. (2013) Mucosal immunity in liver autoimmunity: A comprehensive review. Journal of Autoimmunity 46, pages 97-111.
Crossref
Crossref
John E. Eaton, Jayant A. Talwalkar, Konstantinos N. Lazaridis, Gregory J. Gores & Keith D. Lindor. (2013) Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management. Gastroenterology 145:3, pages 521-536.
Crossref
Crossref
Tom H. Karlsen & Kirsten Muri Boberg. (2013) Update on primary sclerosing cholangitis. Journal of Hepatology 59:3, pages 571-582.
Crossref
Crossref
Jeffrey S. Chang, Chia-Rung Tsai & Li-Tzong Chen. (2013) Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study. PLoS ONE 8:7, pages e69981.
Crossref
Crossref
Palak J. Trivedi & Gideon M. Hirschfield. (2013) Treatment of autoimmune liver disease: current and future therapeutic options. Therapeutic Advances in Chronic Disease 4:3, pages 119-141.
Crossref
Crossref
Said Al Mamari, Jelena Djordjevic, John S. Halliday & Roger W. Chapman. (2013) Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. Journal of Hepatology 58:2, pages 329-334.
Crossref
Crossref
Jawad Ahmad & Adam Slivka. 2013. ERCP. ERCP
430
436.e1
.
A. S.-Y. Leong & C. Pairojkul. 2013. Hilar Cholangiocarcinoma. Hilar Cholangiocarcinoma
25
41
.
G. L. Tyson, S. Keihanian & H. B. El-Serag. 2013. Hilar Cholangiocarcinoma. Hilar Cholangiocarcinoma
17
24
.
Jun Li, Chaochen Zhao & Yuechun Shen. (2012) Autoimmune cholangitis and cholangiocarcinoma. Journal of Gastroenterology and Hepatology 27:12, pages 1783-1789.
Crossref
Crossref
Amir Houshang Mohammad-Alizadeh, Mehdi Ghobakhlou, Hamid Mohaghegh Shalmani & Mohammad Reza Zali. (2012) Cholangiocarcinoma: An-eight-year Experience in a Tertiary-Center in Iran. Asian Pacific Journal of Cancer Prevention 13:11, pages 5381-5384.
Crossref
Crossref
P.J. Trivedi & R.W. Chapman. (2012) PSC, AIH and overlap syndrome in inflammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology 36:5, pages 420-436.
Crossref
Crossref
Mohamad H Imam, Keith D Lindor & Jayant A Talwalkar. (2012) Approaches to the design of clinical trials for primary sclerosing cholangitis. Clinical Investigation 2:8, pages 769-780.
Crossref
Crossref
Lena Sibulesky, Justin Nguyen & Tushar Patel. (2012) Preneoplastic conditions underlying bile duct cancer. Langenbeck's Archives of Surgery 397:6, pages 861-867.
Crossref
Crossref
Neil Bhardwaj & David M. Lloyd. 2012. Handbook of Gastrointestinal Cancer. Handbook of Gastrointestinal Cancer
182
210
.
Andreas E. Kremer & Ulrich Beuers. (2012) Brushing of bile duct stenoses for the true dignity. Liver International 32:5, pages 698-700.
Crossref
Crossref
Leena Halme, Johanna Arola, Kirsti Numminen, Leena Krogerus, Heikki Mäkisalo & Martti Färkkilä. (2011) Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity. Liver International 32:5, pages 783-789.
Crossref
Crossref
Konstantinos N. Lazaridis & Gregory J. Gores. 2012. Textbook of Clinical Gastroenterology and Hepatology. Textbook of Clinical Gastroenterology and Hepatology
580
585
.
Maria Benito de Valle, Einar Björnsson & Björn Lindkvist. (2011) Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population‐based cohort. Liver International 32:3, pages 441-448.
Crossref
Crossref
Elisabeth Krones, Ivo Graziadei, Michael Trauner & Peter Fickert. (2011) Evolving concepts in primary sclerosing cholangitis. Liver International 32:3, pages 352-369.
Crossref
Crossref
Eun Yeong KimHyo Jong KimChang Kyun LeeChoul Ki ParkHee Jae HyunYeon Ju KimKyung Yup Kim. (2012) A Case of Cholangiocarcinoma and Colorectal Cancer Diagnosed Simultaneously in a Patient with Ulcerative Colitis and Concurrent Primary Sclerosing Cholangitis. Intestinal Research 10:4, pages 392.
Crossref
Crossref
Kenji Hirano, Minoru Tada, Suguru Mizuno, Hiroyuki Isayama, Naminatsu Takahara, Rie Nagano, Tsuyoshi Hamada, Koji Miyabayashi, Yukiko Ito, Dai Mohri, Kazumichi Kawakubo, Takashi Sasaki, Hirofumi Kogure, Natsuyo Yamamoto, Naoki Sasahira, Noriyo Yamashiki, Yasuhiko Sugawara, Norihiro Kokudo, Nobuo Toda & Kazuhiko Koike. (2012) Lower Incidence of Biliary Carcinoma in Patients With Primary Sclerosing Cholangitis and High Serum Levels of Immunoglobulin E. Clinical Gastroenterology and Hepatology 10:1, pages 79-83.
Crossref
Crossref
Pierre Bedossa & Valérie Paradis. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
1223
1249.e5
.
Tom H. Karlsen, Kirsten Muri Boberg & Erik Schrumpf. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
754
781
.
Zachary D. Goodman, Luigi M. Terracciano & Aileen Wee. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
761
851
.
Yoh Zen, Alberto Quaglia, Nigel Heaton, Mohamed Rela & Bernard Portmann. (2011) Two distinct pathways of carcinogenesis in primary sclerosing cholangitis. Histopathology 59:6, pages 1100-1110.
Crossref
Crossref
Kirsten Muri Boberg & Guro E. Lind. (2011) Primary sclerosing cholangitis and malignancy. Best Practice & Research Clinical Gastroenterology 25:6, pages 753-764.
Crossref
Crossref
Trine Folseraas, Espen Melum, Andre Franke & Tom H. Karlsen. (2011) Genetics in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 25:6, pages 713-726.
Crossref
Crossref
Nataliya Razumilava, Gregory J. Gores & Keith D. Lindor. (2011) Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54:5, pages 1842-1852.
Crossref
Crossref
David R. Lichtenstein. (2011) Hepatobiliary Complications of Inflammatory Bowel Disease. Current Gastroenterology Reports 13:5, pages 495-505.
Crossref
Crossref
M. Giovannini, E. Bories, G. Monges, C. Pesenti, F. Caillol & J. R. Delpero. (2011) Results of a phase I?II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis. Surgical Endoscopy 25:7, pages 2247-2253.
Crossref
Crossref
Gia L. Tyson & Hashem B. El-Serag. (2011) Risk factors for cholangiocarcinoma. Hepatology 54:1, pages 173-184.
Crossref
Crossref
E. L. Culver & R. W. Chapman. (2011) Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 33:12, pages 1273-1291.
Crossref
Crossref
Albert Parés. (2011) Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento. Gastroenterología y Hepatología 34:1, pages 41-52.
Crossref
Crossref
Piotr Milkiewicz & Ewa Wunsch. 2011. Inflammation and Gastrointestinal Cancers. Inflammation and Gastrointestinal Cancers
117
133
.
Marina G. Silveira & Keith D. Lindor. 2011. Molecular Pathology of Liver Diseases. Molecular Pathology of Liver Diseases
741
752
.
Domenico Alvaro, Renato Cannizzaro, Roberto Labianca, Francesca Valvo & Fabio Farinati. (2010) Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Digestive and Liver Disease 42:12, pages 831-838.
Crossref
Crossref
Dong Kuang & Guo-Ping Wang. (2010) Hilar cholangiocarcinoma: Pathology and tumor biology. Frontiers of Medicine in China 4:4, pages 371-377.
Crossref
Crossref
Tom H. Karlsen, Erik Schrumpf & Kirsten Muri Boberg. (2010) Primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 24:5, pages 655-666.
Crossref
Crossref
Domenico Alvaro, Emanuele Crocetti, Stefano Ferretti, Maria Consiglia Bragazzi & Riccardo Capocaccia. (2010) Descriptive epidemiology of cholangiocarcinoma in Italy. Digestive and Liver Disease 42:7, pages 490-495.
Crossref
Crossref
Tom H. Karlsen, Erik Schrumpf & Kirsten M. Boberg. (2010) Update on primary sclerosing cholangitis. Digestive and Liver Disease 42:6, pages 390-400.
Crossref
Crossref
Sue Cullen & Roger Chapman. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
528
552
.
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio & Domenico Alvaro. (2010) Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 42:4, pages 253-260.
Crossref
Crossref
C. de Martel, M. Plummer & S. Franceschi. (2010) Cholangiocarcinoma: Descriptive epidemiology and risk factors. Gastroent?rologie Clinique et Biologique 34:3, pages 173-180.
Crossref
Crossref
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider & Gregory J. Gores. (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51:2, pages 660-678.
Crossref
Crossref
Siu-Tong Law, Wai-Ki Lee, Michael Kin-Kong Li & Ka-Ho Lok. (2010) A Gentleman with Anemia and Cholestasis. Case Reports in Medicine 2010, pages 1-4.
Crossref
Crossref
Andrew S. Ross & Kris V. Kowdley. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
1153
1170.e6
.
Jayant A. Talwalkar & Nicholas F. LaRusso. 2010. GI/Liver Secrets. GI/Liver Secrets
142
150
.
Guido Michels & Thorsten SchneiderH.-M. Steffen. 2010. Klinikmanual Innere Medizin. Klinikmanual Innere Medizin
416
449
.
Susan Tsai & Timothy M. Pawlik. (2009) Primary Sclerosing Cholangitis: The Role of Extrahepatic Biliary Resection. Advances in Surgery 43:1, pages 175-188.
Crossref
Crossref
Stephanie Koplin & Rashmi Agni. (2009) Hepatic composite tumor in a patient with primary sclerosing cholangitis. Pathology - Research and Practice 205:5, pages 361-364.
Crossref
Crossref
K. D. Lindor. 2009. Bile Acid Biology and Therapeutic Actions. Bile Acid Biology and Therapeutic Actions
255
258
.
Teru Kumagi, Khalid Alswat, Gideon M. Hirschfield & Jenny Heathcote. (2008) New insights into autoimmune liver diseases. Hepatology Research 38:8, pages 745-761.
Crossref
Crossref
Jens J. W. Tischendorf, Andreas Geier & Christian Trautwein. (2008) Current diagnosis and management of primary sclerosing cholangitis. Liver Transplantation 14:6, pages 735-746.
Crossref
Crossref
T Kitiyakara & R W Chapman. (2008) Chemoprevention and screening in primary sclerosing cholangitis. Postgraduate Medical Journal 84:991, pages 228-237.
Crossref
Crossref
Tom H Karlsen, Erik Schrumpf & Kirsten Muri Boberg. (2008) Gallbladder polyps in primary sclerosing cholangitis: not so benign. Current Opinion in Gastroenterology 24:3, pages 395-399.
Crossref
Crossref
B.E. Van Beers. (2008) Diagnosis of cholangiocarcinoma. HPB 10:2, pages 87-93.
Crossref
Crossref
Displaying 200 of 242 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list